Treatment with Allopurinol is Associated with Lower Risk of Acute Kidney Injury in Patients with Gout: A Retrospective Analysis of a Nested Cohort

por Perez-Ruiz, Fernando
Publicado 2017

Improving adherence to gout therapy: an expert review

por Perez-Ruiz, Fernando, Desideri, Giovambattista
Publicado 2018

A Review of Uric Acid, Crystal Deposition Disease, and Gout

por Perez-Ruiz, Fernando, Dalbeth, Nicola, Bardin, Tomas
Publicado 2014

High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?

por Perez-Ruiz, Fernando, Perez-Herrero, Nuria, Richette, Pascal, Stack, Austin G.
Publicado 2020

Gout. Imaging of gout: findings and utility

por Perez-Ruiz, Fernando, Dalbeth, Nicola, Urresola, Aranzazu, de Miguel, Eugenio, Schlesinger, Naomi
Publicado 2009

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol

por Perez-Ruiz, Fernando, Sundy, John S, Miner, Jeffrey N, Cravets, Matthew, Storgard, Chris
Publicado 2016

Computational Lexical Analysis of the Language Commonly Used to Describe Gout

por Lawrence Edwards, N., Malouf, Robert, Perez‐Ruiz, Fernando, Richette, Pascal, Southam, Siobhan, DiChiara, Matthew
Publicado 2016

Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study

por Dalbeth, Nicola, Jones, Graeme, Terkeltaub, Robert, Khanna, Dinesh, Fung, Maple, Baumgartner, Scott, Perez-Ruiz, Fernando
Publicado 2019

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout

por Pérez-Ruiz, Fernando, Jansen, Tim, Tausche, Anne-Katrin, Juárez-Campo, Mónica, Gurunath, Ravichandra Karra, Richette, Pascal
Publicado 2019

Reassessing the Safety Profile of Lesinurad in Combination with Xanthine Oxidase Inhibitor Therapy

por Perez-Ruiz, Fernando, Jansen, Tim L., Tausche, Anne-Kathrin, Richette, Pascal, Lioté, Frédéric, So, Alexander K., Stack, Austin
Publicado 2019

Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality

por Pérez Ruiz, Fernando, Richette, Pascal, Stack, Austin G, Karra Gurunath, Ravichandra, García de Yébenes, Ma Jesus, Carmona, Loreto
Publicado 2019

One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study

por Uhlig, Till, Karoliussen, Lars F., Sexton, Joe, Kvien, Tore K., Haavardsholm, Espen A., Perez-Ruiz, Fernando, Hammer, Hilde Berner
Publicado 2022

Temporal trends in hyperuricaemia in the Irish health system from 2006-2014: A cohort study

por Kumar A. U., Arun, Browne, Leonard D., Li, Xia, Adeeb, Fahd, Perez-Ruiz, Fernando, Fraser, Alexander D., Stack, Austin G.
Publicado 2018

The burden of disease in Spain: results from the global burden of disease study 2010

por Haro, Josep Maria, Tyrovolas, Stefanos, Garin, Noe, Diaz-Torne, Cesar, Carmona, Loreto, Sanchez-Riera, Lidia, Perez-Ruiz, Fernando, Murray, Christopher JL
Publicado 2014

Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

por Dalbeth, Nicola, Jones, Graeme, Terkeltaub, Robert, Khanna, Dinesh, Kopicko, Jeff, Bhakta, Nihar, Adler, Scott, Fung, Maple, Storgard, Chris, Baumgartner, Scott, Perez‐Ruiz, Fernando
Publicado 2017

Understanding the patient voice in gout: a quantitative study conducted in Europe

por De Meulemeester, Marc, Mateus, Elsa, Wieberneit-Tolman, Hilda, Betteridge, Neil, Ireland, Lucy, Petersen, Gudula, Maske, Nina Jeanette, Jansen, Tim L, Perez-Ruiz, Fernando
Publicado 2020

Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence s...

por Cohen, Stanley, Genovese, Mark C, Choy, Ernest, Perez-Ruiz, Fernando, Matsumoto, Alan, Pavelka, Karel, Pablos, Jose L, Rizzo, Warren, Hrycaj, Pawel, Zhang, Nan, Shergy, William, Kaur, Primal
Publicado 2017

Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopur...

por MacDonald, Thomas M, Ford, Ian, Nuki, George, Mackenzie, Isla S, De Caterina, Raffaele, Findlay, Evelyn, Hallas, Jesper, Hawkey, Christopher J, Ralston, Stuart, Walters, Matthew, Webster, John, McMurray, John, Perez Ruiz, Fernando, Jennings, Claudine G
Publicado 2014

Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies

por Nielsen, Sabrina M, Bartels, Else M, Henriksen, Marius, Wæhrens, Eva E, Gudbergsen, Henrik, Bliddal, Henning, Astrup, Arne, Knop, Filip K, Carmona, Loreto, Taylor, William J, Singh, Jasvinder A, Perez-Ruiz, Fernando, Kristensen, Lars E, Christensen, Robin
Publicado 2017

Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables

por Silva-Díaz, Maite, Blanco, Francisco J., Quevedo Vila, Víctor, Seoane-Mato, Daniel, Pérez-Ruiz, Fernando, Juan-Mas, Antonio, Pego-Reigosa, José M., Narváez, Javier, Quilis, Neus, Cortés, Raúl, Romero Pérez, Antonio, Fábregas Canales, Dolores, Font Gayá, Teresa, Bordoy Ferrer, Carolina, Prado-Galbarro, Francisco Javier, Sánchez-Piedra, Carlos, Díaz-González, Federico, Bustabad-Reyes, Sagrario
Publicado 2021